GERRESHEIMER AG (GXI.DE) Stock Fundamental Analysis
FRA:GXI - Deutsche Boerse Ag - DE000A0LD6E6 - Common Stock - Currency: EUR
Taking everything into account, GXI scores 3 out of 10 in our fundamental rating. GXI was compared to 16 industry peers in the Life Sciences Tools & Services industry. GXI has a medium profitability rating, but doesn't score so well on its financial health evaluation. GXI has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
GXI had positive earnings in the past year.
In the past year GXI had a positive cash flow from operations.
In the past 5 years GXI has always been profitable.
GXI had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 1.63%, GXI is doing worse than 62.50% of the companies in the same industry.
GXI has a Return On Equity (5.20%) which is in line with its industry peers.
GXI's Return On Invested Capital of 4.57% is in line compared to the rest of the industry. GXI outperforms 43.75% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for GXI is in line with the industry average of 6.91%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.63% | ||
| ROE | 5.2% | ||
| ROIC | 4.57% |
ROA(3y)3.04%
ROA(5y)3.09%
ROE(3y)7.67%
ROE(5y)8.3%
ROIC(3y)6.14%
ROIC(5y)6.08%
1.3 Margins
GXI's Profit Margin of 3.77% is on the low side compared to the rest of the industry. GXI is outperformed by 62.50% of its industry peers.
In the last couple of years the Profit Margin of GXI has remained more or less at the same level.
With a Operating Margin value of 8.65%, GXI is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
GXI's Operating Margin has improved in the last couple of years.
The Gross Margin of GXI (28.95%) is worse than 75.00% of its industry peers.
GXI's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.65% | ||
| PM (TTM) | 3.77% | ||
| GM | 28.95% |
OM growth 3Y-0.21%
OM growth 5Y2.69%
PM growth 3Y-1.23%
PM growth 5Y-1.47%
GM growth 3Y0.37%
GM growth 5Y1.38%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), GXI is destroying value.
GXI has about the same amout of shares outstanding than it did 1 year ago.
GXI has more shares outstanding than it did 5 years ago.
GXI has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 0.88, we must say that GXI is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.88, GXI is not doing good in the industry: 87.50% of the companies in the same industry are doing better.
GXI has a Debt/Equity ratio of 0.60. This is a neutral value indicating GXI is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.60, GXI is in line with its industry, outperforming 43.75% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.6 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.88 |
ROIC/WACC0.59
WACC7.69%
2.3 Liquidity
GXI has a Current Ratio of 0.61. This is a bad value and indicates that GXI is not financially healthy enough and could expect problems in meeting its short term obligations.
GXI has a worse Current ratio (0.61) than 93.75% of its industry peers.
GXI has a Quick Ratio of 0.61. This is a bad value and indicates that GXI is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.34, GXI is doing worse than 93.75% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.61 | ||
| Quick Ratio | 0.34 |
3. Growth
3.1 Past
GXI shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -0.88%.
The Earnings Per Share has been decreasing by -8.23% on average over the past years.
The Revenue has been growing slightly by 4.55% in the past year.
GXI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.90% yearly.
EPS 1Y (TTM)-0.88%
EPS 3Y4.26%
EPS 5Y-8.23%
EPS Q2Q%-29.23%
Revenue 1Y (TTM)4.55%
Revenue growth 3Y10.77%
Revenue growth 5Y7.9%
Sales Q2Q%11.57%
3.2 Future
The Earnings Per Share is expected to grow by 10.54% on average over the next years. This is quite good.
Based on estimates for the next years, GXI will show a quite strong growth in Revenue. The Revenue will grow by 8.77% on average per year.
EPS Next Y12.58%
EPS Next 2Y14.26%
EPS Next 3Y15.62%
EPS Next 5Y10.54%
Revenue Next Year21.4%
Revenue Next 2Y14.56%
Revenue Next 3Y12.32%
Revenue Next 5Y8.77%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
GXI is valuated reasonably with a Price/Earnings ratio of 10.84.
100.00% of the companies in the same industry are more expensive than GXI, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.45. GXI is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 7.97 indicates a rather cheap valuation of GXI.
Based on the Price/Forward Earnings ratio, GXI is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.90, GXI is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.84 | ||
| Fwd PE | 7.97 |
4.2 Price Multiples
81.25% of the companies in the same industry are more expensive than GXI, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 9.09 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
GXI's earnings are expected to grow with 15.62% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.86
PEG (5Y)N/A
EPS Next 2Y14.26%
EPS Next 3Y15.62%
5. Dividend
5.1 Amount
GXI has a yearly dividend return of 0.08%, which is pretty low.
Compared to an average industry Dividend Yield of 0.72, GXI's dividend is way lower than its industry peers. On top of this 81.25% of the companies listed in the same industry pay a better dividend than GXI!
With a Dividend Yield of 0.08, GXI pays less dividend than the S&P500 average, which is at 2.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.08% |
5.2 History
The dividend of GXI has a limited annual growth rate of 0.94%.
Dividend Growth(5Y)0.94%
Div Incr Years0
Div Non Decr Years6
5.3 Sustainability
GXI pays out 56.16% of its income as dividend. This is a bit on the high side, but may be sustainable.
GXI's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP56.16%
EPS Next 2Y14.26%
EPS Next 3Y15.62%
FRA:GXI (7/4/2025, 7:00:00 PM)
48.68
-0.16 (-0.33%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners87.13%
Inst Owner ChangeN/A
Ins Owners4.92%
Ins Owner ChangeN/A
Market Cap1.68B
Analysts73.33
Price Target75.08 (54.23%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.08% |
Yearly Dividend1.32
Dividend Growth(5Y)0.94%
DP56.16%
Div Incr Years0
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)18.31%
Min EPS beat(2)17.79%
Max EPS beat(2)18.84%
EPS beat(4)3
Avg EPS beat(4)10.77%
Min EPS beat(4)-2%
Max EPS beat(4)18.84%
EPS beat(8)5
Avg EPS beat(8)4.46%
EPS beat(12)8
Avg EPS beat(12)4.54%
EPS beat(16)9
Avg EPS beat(16)2.98%
Revenue beat(2)0
Avg Revenue beat(2)-1.15%
Min Revenue beat(2)-1.59%
Max Revenue beat(2)-0.72%
Revenue beat(4)0
Avg Revenue beat(4)-1.1%
Min Revenue beat(4)-1.59%
Max Revenue beat(4)-0.72%
Revenue beat(8)2
Avg Revenue beat(8)-0.89%
Revenue beat(12)5
Avg Revenue beat(12)-0.41%
Revenue beat(16)6
Avg Revenue beat(16)-0.13%
PT rev (1m)-21.58%
PT rev (3m)-26.29%
EPS NQ rev (1m)-10.75%
EPS NQ rev (3m)-24.21%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.28%
Revenue NQ rev (1m)-1.1%
Revenue NQ rev (3m)-1.98%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.28%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.84 | ||
| Fwd PE | 7.97 | ||
| P/S | 0.8 | ||
| P/FCF | N/A | ||
| P/OCF | 9.07 | ||
| P/B | 1.11 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.09 |
EPS(TTM)4.49
EY9.22%
EPS(NY)6.11
Fwd EY12.55%
FCF(TTM)-5.44
FCFYN/A
OCF(TTM)5.36
OCFY11.02%
SpS60.5
BVpS43.79
TBVpS-7.82
PEG (NY)0.86
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.63% | ||
| ROE | 5.2% | ||
| ROCE | 6.16% | ||
| ROIC | 4.57% | ||
| ROICexc | 4.87% | ||
| ROICexgc | 13.87% | ||
| OM | 8.65% | ||
| PM (TTM) | 3.77% | ||
| GM | 28.95% | ||
| FCFM | N/A |
ROA(3y)3.04%
ROA(5y)3.09%
ROE(3y)7.67%
ROE(5y)8.3%
ROIC(3y)6.14%
ROIC(5y)6.08%
ROICexc(3y)6.5%
ROICexc(5y)6.42%
ROICexgc(3y)14.47%
ROICexgc(5y)16.32%
ROCE(3y)8.29%
ROCE(5y)8.2%
ROICexcg growth 3Y-17.1%
ROICexcg growth 5Y-18.13%
ROICexc growth 3Y-1.3%
ROICexc growth 5Y1.06%
OM growth 3Y-0.21%
OM growth 5Y2.69%
PM growth 3Y-1.23%
PM growth 5Y-1.47%
GM growth 3Y0.37%
GM growth 5Y1.38%
F-Score3
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.6 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 2.29 | ||
| Cap/Depr | 170.95% | ||
| Cap/Sales | 17.86% | ||
| Interest Coverage | 2.93 | ||
| Cash Conversion | 46.44% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.61 | ||
| Quick Ratio | 0.34 | ||
| Altman-Z | 0.88 |
F-Score3
WACC7.69%
ROIC/WACC0.59
Cap/Depr(3y)167.14%
Cap/Depr(5y)152.09%
Cap/Sales(3y)15.92%
Cap/Sales(5y)14.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-0.88%
EPS 3Y4.26%
EPS 5Y-8.23%
EPS Q2Q%-29.23%
EPS Next Y12.58%
EPS Next 2Y14.26%
EPS Next 3Y15.62%
EPS Next 5Y10.54%
Revenue 1Y (TTM)4.55%
Revenue growth 3Y10.77%
Revenue growth 5Y7.9%
Sales Q2Q%11.57%
Revenue Next Year21.4%
Revenue Next 2Y14.56%
Revenue Next 3Y12.32%
Revenue Next 5Y8.77%
EBIT growth 1Y-15.63%
EBIT growth 3Y10.54%
EBIT growth 5Y10.8%
EBIT Next Year139.92%
EBIT Next 3Y43.59%
EBIT Next 5Y26.2%
FCF growth 1Y-179.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y8.34%
OCF growth 3Y4.26%
OCF growth 5Y4.49%